Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
4.180
+0.130 (3.21%)
At close: Apr 3, 2025, 4:00 PM
4.300
+0.120 (2.87%)
After-hours: Apr 3, 2025, 7:49 PM EDT

Dogwood Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Selling, General & Admin
8.73.724.254.859.81
Upgrade
Research & Development
3.531.738.0710.80.19
Upgrade
Operating Expenses
12.235.4512.3215.6410.01
Upgrade
Operating Income
-12.23-5.45-12.32-15.64-10.01
Upgrade
Interest Expense
-0.09----0.38
Upgrade
Interest & Investment Income
-0.150.070.01-
Upgrade
Currency Exchange Gain (Loss)
-0.03----
Upgrade
Other Non Operating Income (Expenses)
----0.04
Upgrade
EBT Excluding Unusual Items
-12.35-5.3-12.25-15.64-10.35
Upgrade
Legal Settlements
----0.33-
Upgrade
Pretax Income
-12.35-5.3-12.25-15.96-10.35
Upgrade
Income Tax Expense
-0----
Upgrade
Net Income
-12.35-5.3-12.25-15.96-10.35
Upgrade
Preferred Dividends & Other Adjustments
0.51----
Upgrade
Net Income to Common
-12.86-5.3-12.25-15.96-10.35
Upgrade
Shares Outstanding (Basic)
11000
Upgrade
Shares Outstanding (Diluted)
11000
Upgrade
Shares Change (YoY)
36.84%69.62%32.91%69.06%1.96%
Upgrade
EPS (Basic)
-12.52-7.05-27.66-47.90-52.50
Upgrade
EPS (Diluted)
-12.52-7.05-27.66-48.00-52.50
Upgrade
EBIT
-12.23-5.45-12.32-15.64-10.01
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q